Among patients with Type 2 diabetes, weight reduction averaged only 23% after 72 weeks
The program may not be the right fit for anyone who requires in-person clinical evaluation, anyone outside the eligible state list, anyone uncomfortable with the non-refundable consultation policy, or anyone whose medical history may be excluded under the published criteria
These GLP-1 receptor agonist medicines are injected once weekly
I provide details regarding the development of GLP-1 receptor agonists for anti-obesity therapy and discuss the possible mechanism behind their beneficial effects on adverse cardiovascular events
Its not about expanding scope to grab more patients its an extension of comprehensive care for the patients I already see. Hes not alone
They are not designed to replace nutrition, movement, hydration, or follow-up care